Amedisys Total Long Term Liabilities 2010-2024 | AMED

Amedisys total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
Amedisys Annual Total Long Term Liabilities
(Millions of US $)
2023 $467
2022 $514
2021 $506
2020 $300
2019 $294
2018 $12
2017 $82
2016 $92
2015 $96
2014 $110
2013 $42
2012 $72
2011 $116
2010 $204
2009 $207
Amedisys Quarterly Total Long Term Liabilities
(Millions of US $)
2024-09-30 $453
2024-06-30 $459
2024-03-31 $462
2023-12-31 $467
2023-09-30 $466
2023-06-30 $459
2023-03-31 $461
2022-12-31 $514
2022-09-30 $545
2022-06-30 $535
2022-03-31 $508
2021-12-31 $506
2021-09-30 $534
2021-06-30 $274
2021-03-31 $328
2020-12-31 $300
2020-09-30 $407
2020-06-30 $481
2020-03-31 $444
2019-12-31 $294
2019-09-30 $294
2019-06-30 $330
2019-03-31 $366
2018-12-31 $12
2018-09-30 $61
2018-06-30 $130
2018-03-31 $82
2017-12-31 $82
2017-09-30 $84
2017-06-30 $87
2017-03-31 $90
2016-12-31 $92
2016-09-30 $93
2016-06-30 $93
2016-03-31 $94
2015-12-31 $96
2015-09-30 $101
2015-06-30 $89
2015-03-31 $92
2014-12-31 $110
2014-09-30 $108
2014-06-30 $139
2014-03-31 $40
2013-12-31 $42
2013-09-30 $44
2013-06-30 $44
2013-03-31 $48
2012-12-31 $72
2012-09-30 $72
2012-06-30 $72
2012-03-31 $73
2011-12-31 $116
2011-09-30 $125
2011-06-30 $195
2011-03-31 $196
2010-12-31 $204
2010-09-30 $197
2010-06-30 $203
2010-03-31 $199
2009-12-31 $207
2009-09-30 $212
2009-06-30 $223
2009-03-31 $291
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.953B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.347B 11.70
Quest Diagnostics (DGX) United States $18.293B 18.54
DaVita (DVA) United States $13.459B 17.41
Encompass Health (EHC) United States $10.015B 23.61
Chemed (CHE) United States $8.477B 26.05
Elanco Animal Health (ELAN) United States $6.624B 15.77
RadNet (RDNT) United States $6.018B 133.28
Option Care Health (OPCH) United States $3.827B 18.14
LifeStance Health (LFST) United States $2.797B 0.00
Astrana Health (ASTH) United States $2.369B 32.39
Addus HomeCare (ADUS) United States $2.191B 25.71
U.S Physical Therapy (USPH) United States $1.463B 38.47
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.048B 42.36
Atai Life Sciences (ATAI) Germany $0.255B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.008B 0.00
ATI Physical Therapy (ATIP) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00